High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells
-
Published:2023-10-06
Issue:1
Volume:28
Page:
-
ISSN:1083-3021
-
Container-title:Journal of Mammary Gland Biology and Neoplasia
-
language:en
-
Short-container-title:J Mammary Gland Biol Neoplasia
Author:
Balema Wintana,Morton Janelle,Larson Richard A.,Li Li,Velasquez Fred Christian,Fowlkes Natalie W.,Krishnamurthy Savitri,Debeb Bisrat G.,Sevick-Muraca Eva,Woodward Wendy A.
Abstract
AbstractInflammatory breast cancer (IBC) presents as rapid-onset swelling and breast skin changes caused by tumor emboli in the breast and breast skin lymphatics. IBC has been linked with obesity and duration of breastfeeding, but how these factors affect IBC tumor progression is not clear. We modeled the simultaneous effects of diet and weaning in mice on in vivo lymphatic function; on IBC tumor growth; and on aspects of the mammary gland microenvironment before and after IBC (SUM149) xenograft inoculation. We hypothesized that weaning status and diet would have synergistic effects on lymphatic function and the breast microenvironment to enhance IBC tumor growth. Changes in lymphatic structure and function were characterized with in vivo near-infrared fluorescence (NIRF) imaging. Mice were fed either a high-fat diet (HFD; 60 kcal%) or a normal/low-fat diet (LFD; 10 kcal%), bred twice, and subjected to either normal-duration nursing (NW) or forced weaning (FW). SUM149 IBC tumors were implanted at 14 months; images were obtained before and after implantation. Multiparous mice fed HFD showed increased pre-tumor lymphatic pulsing in both the FW and NW groups relative to mice fed LFD. HFD promoted tumor growth independent of weaning time (P = 0.04). Pre-tumor lymphatic pulsing was associated with tumor volume at 8 weeks (P = 0.02) and was significantly correlated with expression of the lymphatic tracking ligand CCL21 (P = 0.05, Table 1). HFD significantly increased the numbers of monocyte-derived IBA1+, CD163+, and CD11c+ cells (P < 0.0001, P < 0.0001, P = 0.0005) in the contralateral, non-tumor-bearing mammary gland. Numbers of lymphangiogenic podoplanin+/IBA1+ macrophages were increased in the ducts of HFD and FW mice (all P < 0.003). HFD in nulliparous mice had a similar increase in lymphatic pulsing at 14 weeks (P = 0.006), indicating that this functional change was independent of parity. We conclude that HFD induced increases in mammary gland lymphatic function, assessed as pulsing rate before tumor initiation, and correlated with inflammation in the mammary gland and increased SUM149 tumor growth. The relationship between diet, lymphatic pulsing, and tumor growth warrants further investigation.
Funder
Susan G. Komen State of Texas Grant for Rare and Aggressive Breast Cancer National Cancer Institute Cancer Prevention and Research Institute of Texas
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Reference30 articles.
1. Balema W, Liu D, Shen Y, El-Zein R, Debeb BG, Kai M, Overmoyer B, Miller KD, Le-Petross HT, Ueno NT, Woodward WA. Inflammatory breast cancer appearance at presentation is associated with overall survival. Cancer Med. 2021;10(18):6261–72. https://doi.org/10.1002/cam4.4170. 2. Mason G, Overmoyer BA, Woodward WA, Badve S, Schneider RJ, Jagsi R, Lang JE, Alpaugh M, Smith K, Miller K. Abstract P6–15–03: Inflammatory breast cancer (IBC) defined: Proposed common diagnostic criteria and scoring - Moving beyond the subjective ‘clinical diagnosis’ of IBC to advance research. Cancer Res. 2020;80(4):6–15. https://doi.org/10.1158/1538-7445.SABCS19-P6-15-03. 3. Barkataki S, Javadekar MJ, Bradfield P, Murphy T, Witmer DD, Van Golen KL. Inflammatory breast cancer: a panoramic overview. J Rare Dis Res Treat. 2018;3(2):37–43. 4. Bonnier P, Charpin C, Lejeune C, Romain S, Tubiana N, Beedassy B, Martin PM, Serment H, Piana L. Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition? Int J Cancer. 1995;62:382–5. https://doi.org/10.1002/ijc.2910620404. 5. Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International consensus on the clinical management of inflammatory breast cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th anniversary conference. J Cancer. 2018;9(8):1437–47. https://doi.org/10.7150/jca.23969.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|